---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-335109"
form_type: "8-K"
ticker: "MYO"
cik: "0001369290"
company_name: "MYOMO, INC."
filed_at: "2026-08-05T20:10:26+00:00"
generated_at: "2026-08-05T20:13:11.091324+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Myomo Q2 revenue $11.7M (+21% YoY); raises FY guidance to $45-47M

## Summary
- Revenue $11.7M, up 21% YoY; gross margin 72.1% vs 62.7% last year.
- Net loss $4.0M ($0.09/share) includes $1.2M non-cash derivative mark; operating loss improved to $2.3M from $4.6M.
- Adjusted EBITDA loss improved 79% to $0.8M from $4.0M.
- Record 255 orders in Q2 (+23% YoY); 53% of revenue from recurring patient sources (up from 26%).
- Raises FY 2026 revenue guidance to $45-47M; Q3 guidance $11.5-12.0M.

## SEC filing metadata
- accession: 0001193125-26-335109
- form_type: 8-K
- ticker: MYO
- cik: 0001369290
- company_name: MYOMO, INC.
- filed_at: 2026-08-05T20:10:26+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369290/000119312526335109/0001193125-26-335109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369290/000119312526335109/myo-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-335109
- JSON: https://secwatch.observer/filing/0001193125-26-335109.json
- Plain text: https://secwatch.observer/filing/0001193125-26-335109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.